Hilary Kramer

Hilary Kramer

Hilary Kramer is one of Wall Street’s most successful equity analysts and investment managers, with a reputation as a leading expert on today’s market movements, stock trends and economic outlook.

She received her MBA from the Wharton School at the University of Pennsylvania and her BA from Wellesley College with honors. Hilary Kramer got her start on Wall Street more than two decades ago at Lehman Brothers and Morgan Stanley where she was an analyst in the investment banking group covering natural resources, diversified industrials and energy companies. She was also the chief investment officer of a family office — overseeing a $5.2 billion global private equity and publicly-traded equity fund, and co-vice chairman of the $500 million Ibero-American Partners Fund (1997 to 2003).

In 2004, Hilary’s A&G Capital formed a specialized research arm and investment fund. The GreenTech 21st Century Master Fund focused on companies engaged in alternative energy, clean technologies, environmental infrastructure and services, agricultural and natural resources.

Today, Hilary Kramer is an in-demand commentator whose work often appears in investing publications such as the Wall Street Journal, New York Post, Bloomberg, Business Insider and Reuters and is a regular on CNBC, CNN and the Fox News Channel, providing stock market insight and economic observations.

Hilary Kramer is also the editor of several financial advisory services designed to help individual investors profit from her stock picking talents: Value Authority, GameChangers, Breakout Stocks, High Octane Trader, Absolute Capital Return, Inner Circle and Inner Circle Pro.

Recent Articles

Under Obamacare, Risks Grow for High-Margin Drug Stocks

The implementation of Obamacare means that reimbursement rates for certain drugs will be cut. Here's what that means for drug stocks like Questcor.

Mall Retail Stocks Find ‘New Normal’

Mall retailers like ANF and AEO may be underpriced due to excessive revenue expectations. It's a new (retail) world out there, and investors need to see why...

Patience Is a Virtue For Investors in 2014

Markets are trading in a tight range to start 2014, and investors should be on the lookout for corrections. Use pullbacks as selective buying opportunities

ICPT: Time to Catch a Rising Star With Intercept Stock?

It's never too late to invest in a long-term winner, and pharmaceutical player Intercept is on a long-term run. Here's why you should join the race...

A Positive Year in 2014…With Some Bumps In the Road

Markets are off to a slow start so far in 2014, but I expect a pickup over the course of the year. However, I also believe stock selectivity will be the key.